U.S. Market for Interventional Cardiology Devices
|発行||iData Research Inc.||商品コード||333112|
|出版日||ページ情報||英文 1004 Pages
|心血管インターベンション装置の米国市場 U.S. Market for Interventional Cardiology Devices|
|出版日: 2018年02月12日||ページ情報: 英文 1004 Pages||
Interventional Cardiology Devices Market - US:
Units Sold, Average Selling Prices, Procedure Volumes, Market Values, Shares, Product Pipeline, Forecasts, SWOT - Coronary Stents, Coronary Balloon Catheters, Balloon-Inflation Devices, Interventional Coronary Catheters, Interventional Coronary Guidewires, Coronary Embolic Protection Devices, Coronary Atherectomy Devices, Coronary Thrombectomy Devices, Coronary Chronic Total Occlusion System, Introducer Sheaths, Coronary Vascular Closure Devices, Diagnostic Coronary Catheters and Guidewires, Intravascular Ultrasound, Optical Coherence Tomography: 2018-2024.
The total market value includes a large number of segments such as the coronary stent, coronary balloon catheter, balloon-inflation device, interventional coronary catheter, interventional coronary guidewire, coronary embolic protection device, coronary atherectomy device, coronary thrombectomy device, chronic total occlusion system, introducer sheath, coronary vascular closure device, diagnostic coronary catheter and guidewire, intravascular ultrasound (IVUS) and optical coherence tomography (OCT) markets.
While this report suite contains all US interventional cardiology device data, each of the markets are also available as stand alone MedCore reports. This allows you to get access to only the interventional cardiology market research that you need. You can view all these included reports and segmentation here:
Buying all of these reports together in this suite package will provide you with substantial discounts from the separate prices. Request Pricing to Learn More
Similar to other medical device markets, the interventional cardiology market been experiencing a period of consolidation in recent years. Large competitors are either entering the overall market or expanding their reach by entering new segments through strategic mergers and acquisitions. One trend that has risen as a result of consolidation is the bundling of devices at a discount. Bundling is driven by unfavorable reimbursement conditions and larger competitors who have a wide variety of devices to offer across the interventional cardiology market and are able to negotiate more cost-effective contracts with hospitals and labs. As a result competitive pressure is expected to contribute to declines in prices across the majority of segments in the market.
Of the many companies in the interventional cardiology market, Boston Scientific holds the leading position, with Abbott Laboratories and Medtronic following closely behind. Boston Scientific is an extremely well established competitor in the interventional cardiology field, with a strong reputation and large sales force in both the coronary and peripheral markets. The company has recently emphasized its focus on the complex PCI opportunity in the market, for which it offers specialized devices such as CTO systems, atherectomy devices, specialty balloon catheters, embolic protection devices, IVUS and FFR. The company is expected to maintain its leading position in the market.
In this report suite we've analyzed several other companies, which include market shares from Philips, Terumo, Cardinal Health, and Others.
We've been doing market research for medical devices for over a decade. We specialize in it, and the interventional cardiology market was one of our original reports that helped build trust in our research and methodology. We have built relationships with the top competitors in the interventional cardiology market so that we can gather first-hand information in confidence to assure more accurate research - that our partners and clients then benefit from.
Because we're a third party researcher, we have the ability to reach well into the top interventional cardiology companies and look at a multi-angle approach to our research. Not only do we consider financial filings, we conduct interviews, use hospital and procedural databases, and our own history of research to create a picture of the market that's incredibly accurate.
Our clients have used our interventional cardiology market research for years to strategize new markets to break into, submit SEC filings, decide sales and marketing strategies, plan acquisitions and product launches, and provide a 3rd party source to show investors, boards, and senior executives.